overview & updates on the momentum trial comparing momelotinib and danazol in myelofibrosis
Published 1 year ago • 105 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
2:48
updated results from the momentum trial
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
4:15
the latest data on momelotinib for mpns
-
2:21
clinical updates on the use of momelotinib for mpns
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
3:22
jak2 inhibition in the treatment of myelofibrosis
-
2:40
spread the word, not the bacteria
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
5:58
from bionical emas: the impact of choosing trialhub
-
2:41
an overview of the latest advances in hematology
-
2:48
insight: patient flow management
-
3:09
torin: or management
-
1:22
get to know julia koestner, np
-
0:16
advanced gynecology at main line health | joseph gobern, md, facog
-
4:17
treatment sequencing and ongoing clinical trials in anemic myelofibrosis
-
1:31:40
presentations from authors of cases published in jcem case reports, june 2023, endo 2023
-
1:13
dr. mesa on new trials and agents in the pipeline in myelofibrosis
-
11:47
current clinical landscape in anemic myelofibrosis
-
1:19
the minimally invasive ponto procedure
-
3:37
advancing mpn research: how clinical trials work
-
1:35:53
clinical trial updates